Logo image of KSCP

KNIGHTSCOPE INC-A (KSCP) Stock Fundamental Analysis

NASDAQ:KSCP - Nasdaq - US49907V2016 - Common Stock - Currency: USD

5.63  -0.2 (-3.43%)

Fundamental Rating

3

Overall KSCP gets a fundamental rating of 3 out of 10. We evaluated KSCP against 83 industry peers in the Commercial Services & Supplies industry. While KSCP seems to be doing ok healthwise, there are quite some concerns on its profitability. KSCP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KSCP had negative earnings in the past year.
KSCP had a negative operating cash flow in the past year.
In the past 5 years KSCP always reported negative net income.
KSCP had a negative operating cash flow in each of the past 5 years.
KSCP Yearly Net Income VS EBIT VS OCF VS FCFKSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of KSCP (-104.12%) is worse than 92.77% of its industry peers.
Looking at the Return On Equity, with a value of -170.89%, KSCP is doing worse than 84.34% of the companies in the same industry.
Industry RankSector Rank
ROA -104.12%
ROE -170.89%
ROIC N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KSCP Yearly ROA, ROE, ROICKSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

KSCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KSCP Yearly Profit, Operating, Gross MarginsKSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSCP has less shares outstanding
The number of shares outstanding for KSCP has been reduced compared to 5 years ago.
Compared to 1 year ago, KSCP has a worse debt to assets ratio.
KSCP Yearly Shares OutstandingKSCP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KSCP Yearly Total Debt VS Total AssetsKSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -9.64, we must say that KSCP is in the distress zone and has some risk of bankruptcy.
KSCP has a worse Altman-Z score (-9.64) than 90.36% of its industry peers.
KSCP has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.23, KSCP is doing good in the industry, outperforming 69.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -9.64
ROIC/WACCN/A
WACC9.98%
KSCP Yearly LT Debt VS Equity VS FCFKSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 2.27 indicates that KSCP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.27, KSCP is in the better half of the industry, outperforming 77.11% of the companies in the same industry.
KSCP has a Quick Ratio of 2.06. This indicates that KSCP is financially healthy and has no problem in meeting its short term obligations.
KSCP has a better Quick ratio (2.06) than 81.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.06
KSCP Yearly Current Assets VS Current LiabilitesKSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.12% over the past year.
KSCP shows a decrease in Revenue. In the last year, the revenue decreased by -5.62%.
Measured over the past years, KSCP shows a very strong growth in Revenue. The Revenue has been growing by 28.95% on average per year.
EPS 1Y (TTM)52.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
Revenue 1Y (TTM)-5.62%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%29.41%

3.2 Future

The Earnings Per Share is expected to grow by 25.85% on average over the next years. This is a very strong growth
Based on estimates for the next years, KSCP will show a very strong growth in Revenue. The Revenue will grow by 27.51% on average per year.
EPS Next Y50.03%
EPS Next 2Y25.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.96%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
KSCP Yearly Revenue VS EstimatesKSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
KSCP Yearly EPS VS EstimatesKSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KSCP. In the last year negative earnings were reported.
Also next year KSCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSCP Price Earnings VS Forward Price EarningsKSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KSCP Per share dataKSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as KSCP's earnings are expected to grow with 25.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.85%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KSCP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNIGHTSCOPE INC-A

NASDAQ:KSCP (6/17/2025, 12:01:26 PM)

5.63

-0.2 (-3.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-14 2025-08-14
Inst Owners13.23%
Inst Owner Change176.61%
Ins Owners0.33%
Ins Owner Change0%
Market Cap38.85M
Analysts82.22
Price Target17.34 (207.99%)
Short Float %9.63%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.4%
Min EPS beat(2)10.15%
Max EPS beat(2)60.65%
EPS beat(4)3
Avg EPS beat(4)8.09%
Min EPS beat(4)-40.39%
Max EPS beat(4)60.65%
EPS beat(8)4
Avg EPS beat(8)-0.48%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)12.09%
Min Revenue beat(2)9.12%
Max Revenue beat(2)15.07%
Revenue beat(4)3
Avg Revenue beat(4)18.31%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)57.01%
Revenue beat(8)6
Avg Revenue beat(8)10.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.54%
EPS NQ rev (1m)11.22%
EPS NQ rev (3m)24.02%
EPS NY rev (1m)0%
EPS NY rev (3m)12.69%
Revenue NQ rev (1m)-4.63%
Revenue NQ rev (3m)-5.64%
Revenue NY rev (1m)-2.63%
Revenue NY rev (3m)-2.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.39
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB 2.58
EV/EBITDA N/A
EPS(TTM)-8.14
EYN/A
EPS(NY)-4.52
Fwd EYN/A
FCF(TTM)-2.94
FCFYN/A
OCF(TTM)-2.93
OCFYN/A
SpS1.66
BVpS2.63
TBVpS2.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -104.12%
ROE -170.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 2.06
Altman-Z -9.64
F-Score5
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)9.14%
Cap/Depr(5y)7.03%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
EPS Next Y50.03%
EPS Next 2Y25.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.62%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%29.41%
Revenue Next Year16.96%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.89%
OCF growth 3YN/A
OCF growth 5YN/A